BSX Q3 2022 Earnings — Boston Scientific Corporation Revenue & Financial Results | Market Cap Arena

BSXBoston Scientific Corporation

$105B

Q3 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$3.2B+8.1% YoY

Gross Profit

$1.9B60.8% margin

Operating Income

$460M14.5% margin

Net Income

$188M5.9% margin

EPS (Diluted)

$0.12

QoQ Revenue Growth

-2.3%

Cash Flow

Operating Cash Flow

$470M

Free Cash Flow

$298M

Stock-Based Comp.

$58M

Balance Sheet

Total Assets

$31.9B

Total Liabilities

$14.3B

Stockholders' Equity

$17.6B

Cash & Equivalents

$338M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3.2B	$2.9B	+8.1%
Gross Profit	$1.9B	$1.8B	+5.2%
Operating Income	$460M	$442M	+4.1%
Net Income	$188M	$419M	-55.1%

Revenue Segments

Cardiovascular

$2.1B62%

MedSurg

$1.3B38%

Geographic Segments

UNITED STATES

$1.9B61%

Non-US

$1.2B39%